Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
59.29
+1.04 (1.79%)
At close: Mar 6, 2026, 4:00 PM EST
59.99
+0.70 (1.18%)
After-hours: Mar 6, 2026, 7:49 PM EST
Vaxcyte Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 8,533 | 6,040 | 10,203 | 5,976 | 3,787 | 1,256 | |
| Market Cap Growth | -16.98% | -40.80% | 70.74% | 57.79% | 201.58% | -7.24% | |
| Enterprise Value | 7,090 | 4,413 | 8,050 | 4,724 | 3,445 | 978 | |
| Last Close Price | 59.29 | 46.14 | 81.86 | 62.80 | 47.95 | 23.79 | |
| PB Ratio | 2.89 | 2.25 | 3.09 | 4.82 | 3.97 | 4.42 | |
| P/TBV Ratio | 3.18 | 2.25 | 3.09 | 4.82 | 3.97 | 4.42 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.02 | 0.02 | 0.02 | 0.06 | |
| Net Debt / Equity Ratio | -0.54 | -0.54 | -0.51 | -0.85 | -0.96 | -0.81 | |
| Net Debt / EBITDA Ratio | 1.59 | 1.59 | 2.98 | 2.26 | 3.98 | 2.25 | |
| Net Debt / FCF Ratio | 2.03 | 2.03 | 2.93 | 2.88 | 5.18 | 1.79 | |
| Quick Ratio | 7.81 | 7.81 | 12.63 | 7.46 | 23.08 | 8.61 | |
| Current Ratio | 7.91 | 7.91 | 12.76 | 7.54 | 23.26 | 8.93 | |
| Return on Equity (ROE) | -25.59% | -25.59% | -20.41% | -36.67% | -36.12% | -31.78% | |
| Return on Assets (ROA) | -17.72% | -17.72% | -14.47% | -24.23% | -21.82% | -18.07% | |
| Return on Capital Employed (ROCE) | -33.00% | -33.00% | -16.90% | -37.10% | -24.10% | -35.10% | |
| Earnings Yield | -8.98% | -12.69% | -4.55% | -6.73% | -5.90% | -7.97% | |
| FCF Yield | -8.35% | -11.80% | -5.60% | -6.10% | -4.66% | -10.19% | |
| Buyback Yield / Dilution | -11.55% | -11.55% | -25.57% | -49.75% | -24.95% | -75.73% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.